The role of MRI for determining if endometriosis has transformed into cancer has been of recent interest, even though the incidence of this is seen in only 2.5% of women with endometriosis.
Efficacy and safety of distamab vedotin combined with carboplatin and bevacizumab for HER2-expressing platinum-sensitive ovarian cancer with prior PARPi treatment. Clinical characteristics of EAOC ...